Tgfb1i1-KO Mouse
一般名
Tgfb1i1-KO
製品ID
S-KO-05370
背景情報
C57BL/6NCya
系統ID
KOCMP-21804-Tgfb1i1-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Tgfb1i1-KO Mouse(カタログ番号S-KO-05370)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Tgfb1i1-KO
系統ID
KOCMP-21804-Tgfb1i1-B6N-VA
遺伝子名
製品ID
S-KO-05370
遺伝子別名
Hic5, ARA55, TSC-5, hic-5
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conventional knockout
染色体
Chr 7
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000167965
NCBIトランスクリプトID
NM_001289550
ターゲット領域
Exon 1~11
有効領域の大きさ
~6.4 kb
遺伝子研究の概要
Tgfb1i1, also known as TGF-β1 induced transcript 1 or Hic-5, is a cofactor of cellular TGF-β1. It interacts with various nuclear receptors and is involved in multiple biological processes. TGF-β1 signaling pathway, which Tgfb1i1 is associated with, plays a crucial role in cell growth, differentiation, and apoptosis. Tgfb1i1 is important in maintaining normal cellular functions and its dysregulation may lead to various diseases [1,4].
In urothelial carcinoma (UC), in vitro studies and analysis of clinicopathological data showed that overexpression of Tgfb1i1 was significantly correlated with advanced tumor stage. It regulates UC cell proliferation, viability, and induces epithelial-mesenchymal transition (EMT) to facilitate cell migration, promoting tumor aggressiveness in both upper urinary tract urothelial carcinoma (UTUC) and urinary bladder urothelial carcinoma (UBUC) [1].
In hypospadias, maternal exposure to dibutyl phthalate (DBP) suppresses Tgfb1i1, which impairs angiogenesis and the AR signalling pathway. Decreased Tgfb1i1 expression disrupted tube formation and migration in HUVECs, while overexpression promoted these processes [2].
In type II diabetes, upregulation of Tgfb1i1 in hepatic stellate cells (HSCs) exacerbated the development of metabolic-associated fatty liver disease (MAFLD) to steatohepatitis [3].
In bovine fetal ovaries, TGFβ1 increased the expression of Tgfb1i1 in ovarian fibroblasts, and changes in TGFβ signalling during fetal ovary development may be related to polycystic ovary syndrome (PCOS) [4].
In osteosarcoma, PTHR1 may be involved in its progression by regulating the miR-124-3p-AR-Tgfb1i1 axis [5].
In diabetes-mimicking conditions, ET-1 increased the expression of Tgfb1i1 in brain pericytes, triggering senescence and phenotypic changes [6].
In astrocytomas, TGFB1I1-induced EMT contributed to malignant progression [7].
In primary advanced colorectal cancer, the expression levels of TGFB1I1 may be potential biomarkers to predict the effects of FOLFOX4 chemotherapy [8].
TGFB1I1 is a novel marker for the smooth muscle contractile phenotype and is regulated by serum response factor/myocardin protein, and silencing of its expression promotes smooth muscle cell proliferation [9].
In bovine ovarian development, the expression of TGFB1I1 increased from the first trimester to the second and remained at that level in the third trimester, and it was part of the androgen and TGFβ signalling pathways [10].
In conclusion, Tgfb1i1 plays essential roles in multiple biological processes and disease conditions. Studies on Tgfb1i1 in various models have revealed its significance in cancer development such as in urothelial carcinoma and astrocytomas, as well as in non-cancerous diseases like hypospadias, type II diabetes, and potentially PCOS. These findings contribute to a better understanding of disease mechanisms and may provide potential targets for treatment.
References:
1. Liang, Peir-In, Wei, Yu-Ching, Chen, Huan-Da, Chien, Chu-Chun, Chuang, Hao-Wen. 2024. TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma. In The Kaohsiung journal of medical sciences, 40, 269-279. doi:10.1002/kjm2.12798. https://pubmed.ncbi.nlm.nih.gov/38180299/
2. Wu, Lei, Shi, Fei, Zhang, Yongqing, Xia, Shujie, Jiang, Juntao. 2024. Maternal exposure to dibutyl phthalate (DBP) impairs angiogenesis and AR signalling pathway through suppression of TGFB1I1 in hypospadias offspring. In Ecotoxicology and environmental safety, 270, 115941. doi:10.1016/j.ecoenv.2024.115941. https://pubmed.ncbi.nlm.nih.gov/38184977/
3. Dai, Chia-Yen, Tsai, Ying-Ming, Chang, Chao-Yuan, Sun, Chien-Hui, Hsu, Ya-Ling. 2024. Reconstruction of the Hepatic Microenvironment and Pathological Changes Underlying Type II Diabetes through Single-Cell RNA Sequencing. In International journal of biological sciences, 20, 5531-5547. doi:10.7150/ijbs.99176. https://pubmed.ncbi.nlm.nih.gov/39494341/
4. Azumah, Rafiatu, Liu, Menghe, Hummitzsch, Katja, Anderson, Richard A, Rodgers, Raymond J. . Candidate genes for polycystic ovary syndrome are regulated by TGFβ in the bovine foetal ovary. In Human reproduction (Oxford, England), 37, 1244-1254. doi:10.1093/humrep/deac049. https://pubmed.ncbi.nlm.nih.gov/35413103/
5. Li, Shenglong, Wu, Xixi, Pei, Yi, Qiu, Enduo, Zhang, Xiaojing. 2019. PTHR1 May Be Involved in Progression of Osteosarcoma by Regulating miR-124-3p-AR-Tgfb1i1, miR-27a-3p-PPARG-Abca1, and miR-103/590-3p-AXIN2 Axes. In DNA and cell biology, 38, 1323-1337. doi:10.1089/dna.2019.4880. https://pubmed.ncbi.nlm.nih.gov/31536386/
6. Edgerton-Fulton, Mia, Abdul, Yasir, Jamil, Sarah, Ergul, Adviye. . Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions. In Clinical science (London, England : 1979), 138, 1009-1022. doi:10.1042/CS20240328. https://pubmed.ncbi.nlm.nih.gov/39106080/
7. Liu, Yanwei, Hu, Huimin, Wang, Kuanyu, Zhang, Wei, Jiang, Tao. . Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas. In Oncotarget, 5, 12593-606. doi:. https://pubmed.ncbi.nlm.nih.gov/25333259/
8. Li, Shaotang, Lu, Xingrong, Chi, Pan, Pan, Jie. 2012. Identification of Nkx2-3 and TGFB1I1 expression levels as potential biomarkers to predict the effects of FOLFOX4 chemotherapy. In Cancer biology & therapy, 13, 443-9. doi:10.4161/cbt.19298. https://pubmed.ncbi.nlm.nih.gov/22313639/
9. Wang, Xiaobo, Hu, Guoqing, Betts, Courtney, Van De Water, Livingston, Zhou, Jiliang. 2011. Transforming growth factor-β1-induced transcript 1 protein, a novel marker for smooth muscle contractile phenotype, is regulated by serum response factor/myocardin protein. In The Journal of biological chemistry, 286, 41589-41599. doi:10.1074/jbc.M111.250878. https://pubmed.ncbi.nlm.nih.gov/21984848/
10. Hatzirodos, Nicholas, Hummitzsch, Katja, Irving-Rodgers, Helen F, Anderson, Richard A, Rodgers, Raymond J. 2019. Transcript abundance of stromal and thecal cell related genes during bovine ovarian development. In PloS one, 14, e0213575. doi:10.1371/journal.pone.0213575. https://pubmed.ncbi.nlm.nih.gov/30856218/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
